Vol.4,715-722,September1993CellGrowth&Differentiation715IdentificationandCharacterizationofGenesDifferentiallyExpressedinMeningiomas1MaureenMurphy,MarkJ.Pykett,PeterHarnish,KlausD.Zang,andDonnaI..George2DepartmentofGenetics,UniversityofPennsylvaniaSchoolofMedicine,Philadelphia,Pennsylvania19104-6145[M.M.,M.j.P.,P.H.,D.L.G.l,andDepartmentofHumanGenetics,UniversityofSaarland,6650HomburgJSaar,Germany1K.D.Z.lAbstradMeningiomasarecommontumorsderivedfromthethinmembranethatsurroundsthebrainandspinalcord.Currently,themolecularmechanismsresponsiblefortheinitiationandprogressionofthesetumorsarelargelyunknown.Towardtheelucidationofsuchmechanisms,wehaveformulatedanexperimentaldesignutilizingthetechniqueofsubtradivehybridizationthatisaimedatidentifyingthechangesingeneexpressionbetweenintracranialmeningiomasandtheirnormalprecursorcells,leptomeningealcells.Wereportheretheidentificationandinitialcharaderizationofthreegeneswhoseexpressionisalteredoraberrantinmeningiomacelllinesandtumorsrelativetoculturesofnormalleptomeningealcells.ComplementaryDNAprobesfromoneofthesegenesdetedtranscriptsofalteredsizeinseveralmeningiomasrelativetonormalleptomeningealcells.Anotherofthesegenesdemonstratesdecreasedexpressioninmeningiomasandintumorsassociatedwiththedisorderneurofibromatosis2.Athirdgeneisolatedbythisprocedureisdifferentiallyexpressedinbothmeningiomasandbreastcarcinomas.Therefore,thedecreasedexpressionofthesegenesmayplayrolesingrowth-regulatorypathwaysthatareabrogatednotonlyinmeningiomas,butinothertumortypesaswell.IntrodudionMeningiomasareoneofthemostcommontumorsofthecentralnervoussystem.Derivedfromtheleptomeningealmembranesurroundingthebrainandspinalcord,thesetu-morsaccountforupto20%ofallprimaryintracranialtu-morsand25%ofintraspinalneoplasticlesions(1).Clinicallyandhistologically,meningiomascompriseaheterogeneousgroupoftumors,withuptoninedifferentpathologicalandhistologicalsubtypes(1,2);atpresent,thebasisforthishet-erogeneityisunclear.Althoughmeningiomasaregenerallysolitaryandsporadic,familialassociationsofthesetumorshavefrequentlybeenreported(1);theseoccuroften,al-thoughnotalways,inassociationwiththedisorderNF3-2.NF-2isanautosomal-dommnantlyinheriteddisorderpredis-posingaffectedindividualstomultipletumortypesinthecentralnervoussystem,suchasastrocytomas,schwanno-mas,meningiomas,andependymomas;thehallmarkofthedisorderisconsideredtobethepresenceofbilateralyes-tibularschwannomas(3).Cytogeneticstudiesofbothsporadicandfamilialmenin-giomas(4-6),coupledwithrecentanalysesoflossofhet-erozygosityofcertainDNAmarkersinthesetumors(7),havedemonstratedthatlossofgeneticmaterialfromchromosome22issignificantlymorefrequentthanalterationsofotherchromosomesandoccursinupto70%ofmeningiomas(8).Thesedatahaveledtothehypothesisthatthealterationofatumorsuppressorgeneonchromosome22isinvolvedinthegenesisofbothsporadicandfamilialmeningiomas.Thistumorsuppressorgene,whichwerefertoasthemeningiomasusceptibilitylocus,ormsl,hasbeenlocalizedcytogeneti-callyandviadeletionmappingtochromosome22q12-qter(9-11).BecauselinkageanalysesindicatethattheNF-2dis-orderislinkedtolociinthisregionofchromosome22(12,13),anddeletionsoflocifromthischromosomehavebeendetectedintumorsfrompatientsdiagnosedwithNF-2(14),ithasbeenhypothesizedthatthetumorsuppressorgenesinvolvedintheinitiationofmeningiomasandNF-2areal-lelic(15);however,somestudiesindicatethatthesetumorsuppressorsmayrepresenttwoseparatelocionchromo-some22(16).Cytogenetically,meningiomasareoneofthebestchar-acterizedsolidtumorsinhumans.Inadditiontolossofge-neticmaterialfromchromosome22,thesetumorsdisplayother,lessfrequentcytogeneticalterations.Inparticular,re-arrangementsofchromosomes1pand11p,aswellaslossesofgeneticmaterialfromchromosomes8,14,and17,havebeendocumentedtooccurasnonrandomgeneticchangesinthesetumors(17-19).Itisgenerallyfeltthatthesenon-random,secondarychromosomalaberrationsandlossesrepresenttheinactivationofothertumorsuppressorloci,whosefunctionallossmaycontributetomeningiomapro-gression,aggressiveness,orchanceforrecurrence.Recently,subtractivehybridizationhasbeensuccessfullyutilizedintheisolationofcandidategenesforgeneticdis-ease(20,21)andinthedefinitionofthechangesingeneexpressionthatoccurduringthegenesisandprogressionofdifferenttypesofcancer,suchasneuroblastoma(22)andcancersofthebreast(23),liver(24),andlung(25).Werea-sonedthatsuchanapproachwasidealforthestudyofme-ningiomas.Wedescribeheretheuseoftwodifferentsub-Received6/7/93;accepted6/17/93.1ThisprojectwassupportedbytheCooperativeHumanTissueNetwork,whichisfundedbytheNationalCancerInstitute,andbyNIH-USPHSGrantNS30025,awardedtoD.L.G.;M.M.andM.J.P.weresupportedinpartbyNIH-USPHSTrainingGrants5-T32-GM07229and5-T32-GMO7170.2Towhomrequestsforreprintsshouldbeaddressed,atUniversityofPenn-sylvaniaSchoolofMedicine,Room445ClinicalResearchBuilding,422Cu-neBoulevard,Philadelphia,PA19104-6145.3Theabbreviationsusedare:NF,neurofibromatosis;LMC,leptomeningealcells;kb,kilobase(s);bp,basepair(s);RT-PCR,reversetranscription-polymerasechainreaction;ER,estrogenreceptor;IGFBP,insulin-likegrowthfactor-bindingprotein;cDNA,complementaryDNA;SSC,standardsalinecitrate;SDS,sodiumdodecylsulfate;mac,meningiomaalteredexpressioncDNA;ATCC,AmericanTypeCultureCollection;poly(A)(cid:1),polyadenylated.Sccoofstrand(cid:1)adthKionowpolymersas.transformatIonIntoE.coil+I(cid:1)neem(cid:1)Sutersofon(cid:1)IS_adlo(cid:1)Subtracted(cid:1)-,LMC.T(cid:1)996(cid:1)nw+Diltorentialecre(cid:1)wasiobeNedcOttAfromLMCand12896Fig.1.Subtractivehybridizationschemefortheisolationofsequencesen-richedinorspecifictothenormalLMCcDNAlibrary.Leftside,constructionoftheplasmidsubtractionlibrary:rightside,generationofthephagesub-tractionlibrary;thelatterutilizestworoundsofsubtractionfollowedbyPCRtoincreasesensitivity.ss,singlestranded.716GenesDifferentiallyExpressedinMeningiomastractivehybridizatjonprotocolsthatservedtoenrichforcDNAsequencespresentlargelyorexclusivelyinnormalLMCrelativetoameningiomacellline.TheseprotocolsenabledtheidentificationofthreegenesthatareexpressedinnormalLMCbutshowalteredordifferentialexpressioninseveralmeningiomas.Theidentificationandcharacteriza-tionoftheseandothersuchalteredgenesislikelytobeacriticalsteptowarduncoveringtheetiologyandpathologyofthesefrequenttumorsandmayhaveaddedimplicationsforunderstandingthetransformationpathwaystakenbyothertumortypesaswell.ResultsTwodifferentprotocolswereutilizedfortheconstructionandscreeningofsubtractionlibrariesfromnormallepto-meningealcellsandthemeningiomacelllineT2898,asoutlinedbrieflyinFig.1.Inbothcases,subtractivehybrid-izationwasperformedsuchthattheselibrarieswouldbeenrichedforsequencesfoundlargelyorexclusivelyinnor-malLMC,relativetothemeningiomacelllineT2898.Theconstructionoftheplasmid12898subtractionlibraryin-corporatedoneroundofhybridizationandsubtraction,asshowninFig.1;thislibrarywasscreenedwithsimilarlymade“subtractedprobes”madefrommRNAfromnormalLMCandanothermeningiomacellline,designatedT2966.Inanefforttoincreasetheefficiencyofsubtraction,thephageT2898subtractionlibrarywasgenerated;thecon-structionofthislibraryincorporatedtworoundsofhybrid-izationandsubtraction,eachfollowedbyamplificationofLMC-enrichedsequencesviathepolymerasechainreaction.ThephageT2898subtractionlibrarywasdifferentiallyscreened,asdescribedin“MaterialsandMethods.”(cid:1)onstructlonandScreeningofSubtractionLibraries2ugLMCascOttA60ugas1’2886msnlnglomscOttA+‘(cid:1)(cid:1)‘b,Idiz.dtoCoTp8000StreptevidinIncubation/Phenolextraction,61011precIpitation/\pcnw(cid:1)Sp6fll--+Removalof-eequenceeAdditionofScoreadaptorsI60ugas12896menlngiomecOttA+(cid:1)toCoTx8000Sbaptev(cid:1)Incubation/Phenolextraction,E10Hpradon+thor(cid:1)pecmcoligomerLigationkiloLambdaZapN+Fromsubtractedprobeanddifferentialscreeningsofthesetwosubtractionlibraries,30plasmidandphagecloneswererecoveredforsecondaryNorthernanalysis.Ofthese,fouruniquecDNAclonesdetectedapatternorlevelofhybrid-izationinnormalleptomeningealcelltotalRNAthatwasdifferentintheT2898and/or12966meningiomas.Twooftheseclones,althoughofdistinctsequence,hybridizedtothesamepatternofRNAinNorthernanalysesandlikelyrepresentthesamegene.ThethreecDNAclonespresentedinthisstudy,containinginsertsofl.1,0.42,and0.3kb,weredesignatedmac25,mac30,andmacPi,respectively.Themac25GeneIsDifferentiallyExpressedinMenin-giomas,butnotinOtherTumorsofNeuroedodermalOn-gin,IncludingThoseAssociatedwithNF-2.ThecDNAclonedesignatedmac25hybridizestoasingleabundanttranscriptofapproximately1.1kbinRNAisolatedfromcul-turesofnormalIeptomeningealcells(Fig.2A,Lane1)andfromtheLTAg2Bimmortalizedlineofthesecells(Lane10),aswellasinRNAisolateddirectlyfromnormalleptomen-ingealtissue(Lane14).However,asdepictedinFig.2,thiscDNAdetectsdecreasedlevelsofthe1.1-kbtranscriptinRNAisolatedfromseveralmeningiomacelllines(Fig.2A,Lanes2,3,and11-13).Additionally,themac25cDNAprobedetectstheaddedpresenceofahighermolecularweighttranscript,ofapproximately4.0kb,inthespinalme-ningiomaT2966(Fig.2A,Lane3).Furthermore,transcriptshybridizingtothemac25probearevirtuallyundetectableinRNAisolatedfromseveralmeningiomasolidtumors(Fig.2A,Lanes4-9).Incontrast,thesesamesamplesexhibitcom-parablelevelsoftranscriptsfor(cid:1)32-microglobulin(Fig.2A,82M,Lanes1-14),aswellasribosomalRNA(datanotshown).Transcriptlevelsofthemac25genewerenotfoundtobesignificantlydecreasedinRNApreparedfromotherneuro-ectodermallyderivedtumorsortumorcelllines,relativetolevelsinnormalLMC.AsshowninFig.28,significantlevelsofmac25transcriptarepresentinRNAisolatedfromaneu-roblastoma(Lane3),aneurofibroma(Lane5),andagliomacellline(Lane6).Additionally,inanefforttoextendthesestudiestoothertumorsfoundinthedisorderneurofibroma-tosis2,weanalyzedthelevelofexpressionofmac25inRNAisolatedfromaspinalschwannomafromaNF-2patient,aswellasinasporadicspinalschwannoma(Fig.28,Lanes4and6,respectively);inbothsamples,levelsofmac25RNAwereindistinguishablefromthatinculturedLMC(Lane1).Therefore,thedecreasedexpressionofthemac25geneap-pearslimitedtocertainmeningiomacelllinesandsolidtu-morsandisnotcommontoallneuroectodermallyderivedtumors,nortoalltumorsassociatedwiththedisorderNF-2.NorthernblotanalysisofRNAfromnormalmousetissuesindicatesthatthemac25geneisexpressedinabroadspec-trumoftissues,suchasbrain,lung,heartandskeletalmuscle,testes,ovary,andpregnantuterus;thehighestlevelsofmac25transcriptswerefoundinthelattertwotissues(datanotshown).Themac25GeneIsAlsoDifferentiallyExpressedinBreastCarcinomasandHasHomologytoGenesEncodingInsulin-likeGrowthFador-bindingProteins.Therearenu-merousreportsintheliteraturethatindicateastatisticallysignificantclinicalassociationbetweentheoccurrenceofmeningiomasandbreastcarcinoma(26-28).Therefore,inadditiontoexaminingtheexpressionofisolatedmacgenesintumorsassociatedwiththedisorderNF-2,wewerealsointerestedinexaminingtheexpressionofthesegenesinbreastcarcinomasamples.AsdepictedinFig.3,wefoundB.--++CellGrowth&Differentiation717A.10MCT2898T2966SolidTumorsMeningiomaCellLines4.01.1123456789#{149}(cid:1)0mac251011121314B2MOtherTumors/Celllinesmac25B2M(cid:1)(cid:1)(cid:1)Fig.2.A,Northernanalysisofmac25geneexpressioninmeningiomacelllinesandtumors.TenpgoftotalRNAarepresentineachlane;equalloadingsandRNAintegrityarecontrolledbylevelsofribosomalRNA,aswellasRNAforf32-microglobulin(B2M).RNAsamplesineachlaneare:Lane1,normalleptomeningealcells;Lane2,T2898meningiomacellline;Lane3,T2966meningiomacellline;Lanes4-9,meningiomatumorsND1,ND2,A287B,A244,A009,andA188,respectively;Lane10,LTAg2BimmortalizedLMC;Lanes11-13,meningiomacelllinesT2896,T2921,andT2891;Lane14,normalleptomeningealtissue.B,Northernanalysisofmac25expressionin:Lane1,LTAg2Bleptomeningealcells;Lane2,asporadicspinalschwannoma;Lane3,aneuroblastoma;Lane4,aspinalschwannomafromapatientdiagnosedwithNF-2;Lane5,aneurofibroma;Lane6,U-373Mggliomacellline.TenpgoftotalRNAareloadedineachlane.BreastcarcinomasMeningiomasIII567891011++-mac25-estrogenreceptorFig.3.Northernanalysisofmac25geneexpressioninbreastcarcinomasandmeningiomas,comparedtothepositive)+)ornegative(-)presenceofmRNAfortheestrogenreceptorinthesecelllines.ThepresenceofERmRNAwasmeasuredbyaRT-PCRassay.Lane1,RNAfromnormalbreastlineHs578Bst;Lanes2-8,breastcarcinomacelllinesHs578T,ZR-75-30,ZR-75-1,MDA-MB-157,MDA-MB-231,BT-483,andT-47D,respectively;Lane9,ND1meningioma;Lane10,T2888meningiomacellline;Lane11,LTAg2Bleptomeningealcells.thatthemac25geneisexpressedathighlevelsinsomebreastcarcinomacelllines,yetitisundetectablyexpressedinothers(Lanes2-8).Intotal,wefoundmac25expressedathighlevelsinfourbreastcarcinomacelllines,butabsentinexpressioninthree.Itisunlikelythatthedifferencesinlevelsofthistranscriptrepresenttissue-specificchanges,asallsevenofthesecelllinesrepresentedadvancedstagecar-cinomasfrommammaryductalepithelium.Wenotedthattwoofthemac25nonexpressingbreastcarcinomacelllineshadbeenpreviouslyreportedtobepositiveforestrogenreceptorprotein(29).Therefore,wesoughttodeterminewhethertheexpressionofthesetwogenesmightbeinverselycorrelatedinthiscelltype.AsshowninFig.3,wefoundthatthepresenceofERmRNA,asmeasuredinaRT-PCRassay,negativelycorrelateswithmac25geneexpressioninacelllinefromnormalbreasttissue(Hs578Bst;Fig.3,Lane1),andinsevenofeightbreastcarcinomacelllines(Lanes2-8).Onecellline(MDA-MB-453)expressedneitherRNA,however(datanotshown),norwereweabletodetectthepresenceofERmRNAinanyofourmeningiomas(Fig.3,Lanes9-11).Theinversecorre-lationbetweenERandmac25geneexpressioninbreastcar-A.12345678910111213141234567891011mac30losFig.5.A,Northernanalysisoflevelsofmac30geneexpressioninmenin-giornatumorsandcelllines,relativetolevelsoff32-microglobulin(B2M).TenpgoftotalRNAarefrom:Lane1,normalLMC;Lane2,T2966meningiomacellline;Lane3,ND1meningioma;Lane4,ND2meningioma;LaneS,T2898meningiomacellline;Lanes6and11,LTAg2BLMC;Lanes7-1O,meningiomacelllinesT2896,T2921,T2891,andT2888,respectively;Lanes12-14,me-ningiomasA244,A009,andA188,respectively.B,Northernanalysisofmac30expressioninnormalandtransformedhumancelllinesandtissue.Ten(cid:1)igofRNAarefrom:Lane1,normalhumanfibroblasts;Lane2,HeLa;Lane3,RD-ES;Lane4,CoIo32ODM;Lane5,K-562;Lane6,Sk-mel-2;Lane7,U-373Mgglioma;Lane8,Tu-87;Lane9,Hs578T;Lane10,LTAg2B;Lane11,normalleptomeninges.718GenesDifferentiallyExpressedinMeningiomas20mac25PAGLLLLLLPLSSSSSSDTCGPCEPASCPPLPPL11111111I1111IIIIII11111111atiiiiuiiIliii11111111111111RVWLVLLLLTVQVGVTAGAPWQCAPCSAEKLALCPPVSA_IGF#{149}BP192GCLLGETRDA#{212}G#{212}#{212}PM#{212}ARGEGEP#{212}GGGGAGRGY#{212}APGME#{212}III1111111111111111III111111III1111111111111111III111111SCSEVTRSAGCGCCPMCALPLGAACGVATAR__CARGLSC102Fig.4.Aminoacidhomologyattheaminoterminusofthepredictedmac25pr(cid:1)I)teintotheamino-terminal102aminoacidsofthehumanIGFBP-1.In75aminoacids,theseproteinsare37%identicaland75%similar.#{149},conservedcysteineresidues,knowntohecriticaltothefunctionofIGFBPs.cinomacelllinesmayindicatethatthemac25geneises-trogenregulatedinthesecells;however,theabsenceofdetectableERmRNAinourmeningiomassuggeststhatothervariablesmustcontributetothedecreasedexpressionofthisgeneinthesetumors.AsearchoftheGenBankdatabasewiththefull-lengthnucleotidesequenceofthemac25cDNAindicatesthatthesequenceofthisgenehasnotbeenreportedpreviously.Aproteinhomologysearchrevealedthatthe281-aminoacidproteinrepresentingthelargestopenreadingframeofthisgenepossessesasignificantdegreeofhomologyattheaminoterminustotheaminoterminiofseveralmembersoftheIGFBPfamily.Importantly,thishomology,detailedforIGFBP-1inFig.4,includes11ofthe12cysteineresiduesknowntobecriticalforthefunctionofinsulin-likegrowthfactor-bindingproteins(30).AsmightbeexpectedwithaputativememberoftheIGFBPfamily,themac25genedem-onstratesaveryhighspeciesconservation;severalgenomicfragmentshybridizetothemac25cDNAprobeinmultiplespecies,suchasrat,mouse,dog,andmonkey,atwashingstringenciesashighas0.3XSSCat55#{176}C(datanotshown).Preliminarychromosomalmappingstudiesusingarodent!humansomaticcellhybridpanelindicatethatthemac25genemapstohumanchromosome4(datanotshown).Themac3OGeneDemonstratesDecreasedExpressioninMeningiomasandSchwannCellTumors.Themac30cDNA,likemac25,wasisolatedasapositivecloneinthescreeningoftheplasmidT2898subtractionlibrarywithsubtractedprobesmadefromtheT2966meningiomacellline.This421-bpcDNAhybridizestotwotranscriptsofapproximately2.3and2.8kbinRNAisolatedfromnor-malleptomeningealcells(Fig.5A,Lane1)andfromim-mortalizedculturesofthesecells(Lanes6and11).WhenhybridizedtoaNorthernpanelcontainingtotalRNAiso-latedfromfivemeningiomacelllines(Fig.5A,Lanes2,5,and7-10),aswellasRNAprepareddirectlyfromsixme-ningiomatumors(Lanes3,4,and12-14),thiscDNAprobedetectssignificantlydecreasedexpressionofthisgene.Incontrast,thesesamplesdemonstratecomparablelevelsoff32-microglobulin(Fig.5A,Lanes1-14)andribosomalRNA(datanotshown).Thusfar,transcriptshybridizingtomac30havebeendetectedatlevelscomparabletothatinnormalLMCinover30celllinesfromnormalandtransformedhu-mantissue(see,forexample,Fig.58,Lanes1-11),includingalleightbreastcarcinomacelllines(see,forexample,Lane9),aswellasRNAisolateddirectlyfromleptomeningealtissue(Lane11).Thesedataindicatethatthemac3Ogeneislikelytobenormallyubiquitouslyexpressed,andfurther-more,thatitsdown-regulationisnotcommontoalltrans-formedcells.28Smac3018SB.B2MIneffortstoagainextendthesestudiestothedisorderneu-rofibromatosis2,weanalyzedseveralNF-2tumorsforex-pressionofmac30.UsingaRT-PCRassaytomoreaccuratelydetectmac30transcriptsintumors,wefoundexpressionofmac30tobedramaticallydecreasedinRNApreparationsfromtwovestibularschwannomasandonespinalschwan-noma,allfrompatientsdiagnosedwithneurofibromatosis2(Fig.6A,Lanes2-4),inasporadicvestibularschwannoma(Lane5),andinasporadicspinalschwannoma(Lane6).Somewhatsurprisingly,wealsofoundthemac30genetobesimilarlydecreasedinexpressioninseveralneurofibromas,whichareSchwanncelltumorsoftheperipheralnervoussystemcharacteristicofthedisorderNF-1(Ref.31;Fig.6A,Lanes8-10).Nodecreaseinlevelsofmac3ORNAwerefoundinothertumorsofneuralcrestorigin[forexample,inaneuroblastoma(Fig.6A,Lane7));furthermore,atranscripthybridizingtothiscDNAisclearlypresentinRNAisolatedfromculturesofimmortalizedratSchwanncells(Fig.6B,Lane1).Therefore,decreasedexpressionofthisgeneap-pearstobelimitedtomeningiomatumorsandcelllines,aswellastoSchwanncelltumors,includingthoseassociatedwiththedisordersNF-1andNF-2.Sequenceanalysisofa2.0-kbmac30cDNAandasearchoftheGenBankdatabaseindicatethatthesequenceofthisgenehasnotbeenpreviouslyreportedand,furthermore,thatmac3Dsequencesdonotcontainanysignificanthomologiestopreviouslyreportedgenes.Chromosomalmappingusingarodent/humansomaticcellhybridpanelindicatesthatthisgeneresidesonhumanchromosome17(datanotshown).FurthermappingwiththesomaticcellhybridVII-2HAT(32),whichcontainsthesinglehumantranslocationchromosome(llcen-11pl5::17q21-17qter),indicatesthatthisgenere-sidesonchromosome17q21-qter(datanotshown).ThemacPicDNADetectsTranscriptsofAlteredSizeinManyMeningiomas.Inordertoincreasethesensitivityofoursubtractivehybridizationprotocol,wegeneratedaCellGrowth&Differentiation719A.LMCNF-2tumorsNBNF:1tumors-RIdH2Omac30actin123456789101112IB.Fig.6.A,RT-PCRanalysisofRNAlevelsofmac30andj3-actinintumorsassociatedwiththedisordersNF-2andNE-i.Lane1,normalLMC;Lanes2and3,NF-2vestibularschwannomas;Lane4,NF-2spinalschwannoma;Lane5,sporadicvestibularschwannoma;Lane6,sporadicspinalschwannoma;Lane7,neuroblastoma;Lanes8-10,NF-1neurofibromas;Lane11,minus-reversetranscriptasecontrol;Lane12,watercontrol.B,Northernanalysisofmac3OexpressioninRNAfromanimmortalizedratSchwanncellline(C4+Zn;Lane1)andLTAg2BLMC(Lane2(.RNAblotwaswashedinO.3XSSCat55CCandexposedtofilmfor48h.Arrow,sizeofthemac3Otranscriptinratcells;similarlevelsofatranscriptofthissizeareevidentinRNAfromadultmousebrainaswellascatleptomeningealcultures(notshown(.28S(cid:1),J(cid:1)*fjo18SFig.7.NorthernanalysisofmacPigeneexpressionin:Lane1,normalLMC;Lane2,LTAg2BimmortalizedLMC;Lane3,12898meningiomacellline;Lane4,T2966meningiomacellline;Lane5,ND1meningioma;Lane6,T2921meningiomacellline;Lane7,HeLacells;Lane8,K-562cells;Lane9,RD-EScellline.TenpgoftotalRNAareloaded/lane.phagesubtractionlibrarythatincorporatedtworoundsofsubtraction,eachfollowedbyamplificationofLMC-enrichedsequencesbythepolymerasechainreaction.Dif-ferentialscreeningofthiscDNAlibraryyieldedtheisolationofthemacPicDNA,whichhybridizestotranscriptsofap-proximately5.0,3.5,and3.0kbinnormalandimmortalizedleptomeningealcellRNA(Fig.7,Lanes1and2).InRNAfromthemeningiomaT2898,themacPiprobedetectsde-creasedlevelsofatranscriptthatisconsistentlyreducedinsizerelativetothenormal3.0-kbmessage(Fig.7,Lane3).InRNAsamplesrunlongerforgreaterseparation,thissizedifferenceappearsontheorderof100-200bp(datanotshown).Therefore,inadditiontobeingdecreasedinex-pressionintheT2898meningioma,the3.0-kbmacPltran-scriptmayalsocontainsequencespresentinnormalLMCthataredeletedintheT2898tumor.IntheT2966menin-giomacellline,themajorhybridizingmacPltranscripthasamolecularsizegreaterthan3.0kb,whereasthenormal5.0-kbmessageisundetectable(Fig.7,Lane4).Additionally,RNAisolatedfromanothermeningiomacontainsanabun-danttranscriptofapproximately6kbthathybridizestomacPlprobe(Fig.7,Lane5);yet,othermeningiomashavedemonstratedapatternofhybridizationindistinguishablefromnormalLMC(see,forexample,Fig.7,Lane6).AnalysisofthehybridizationpatternofthemacPigeneinseveralnormalandtransformedhumancelllines,aswellasRNAisolateddirectlyfromnonmeningealtumors,indicatesthattheexpressionofthe5.0-kbtranscriptmaybeubiqui-tous,whereastheexpressionofthe3.0-and3.5-kbtran-scriptsmayberestrictedtonormalLMCandsomemenin-giomas(see,forexample,Fig.7,Lanes7-9).Atpresent,ithasnotbeendeterminedwhetherthethreetranscriptsthathybridizetomacPiinnormalLMCRNAarederivedfromthesameorhomologousgenes.Sequenceanalysisofthe300-bpmacPicDNAclone,aswellasa2.5-kbcDNAfromthisgene,hasrevealednosignificantsequencehomologytosequencesintheGenBankdatabase.DiscussionInthisreport,wedescribetheuseofsubtractivehybridiza-tiontoidentifymRNAdifferencesbetweenapopulationofnormalleptomeningealcellsandameningiomacellline.ItwasexpectedthatcDNAclonesisolatedinthisstudycouldbeclassifiedintoatleastoneofthefollowingcategories:(a)clonesrepresentinggenesinwhichthealterationinexpres-sionisaccompaniedbygenomicmutation;(b)geneswhoseexpressionislostduetotheinitiallossoffunctionofthemslgeneproduct;and(c)geneswhoseexpressionislostinme-ningiomasduetoachangeindifferentiationstateinthesetumorsrelativetonormalLMC.Thefirstclassofgenesin-cludescandidatetumorsuppressorgenes;theunderstandingofthefunctionandcharacteristicsofthelattertwoclassesofgeneswillbecriticaltowardtheunderstandingofthefunc-tionofthenormalms/geneandmayfurtherelucidatesomeaspectsofthebiologyofmeningiomas.Forexample,theexistenceofahormonalinfluenceontheclinicalcourseofmeningiomashaslongbeenacknowl-edged.Thesetumors,whicharemorefrequentinwomen,haveoftenbeenfoundtobecomeclinicallysymptomaticfollowingpregnancyormenstruation(1).Furthermore,theoccurrenceofmeningiomashasbeenfoundtobestatisti-callyassociatedwiththeincidenceofbreastcarcinomainwomen(26-28).Thebasisfortheseassociationsisincom-pletelyunderstood,however;numerousstudieshavefailedtofindconclusiveevidenceinmeningiomasforthewide-spreadpresenceoffunctionalreceptorsforeitherestrogenorprogesterone,althoughthepresenceofandrogenreceptorshasbeenreported(33,34).Wehavefoundthatthemac25genehasthepotentialtoencodeaproteinwithhomologytoafamilyofgrowthfactor-bindingproteinsandisalteredinexpressioninbothmeningiomasandbreastcarcinomas.Furthermore,theexpressionofmac25isinverselycorrelatedinbreastcarcinomaswiththepresenceofmRNAfortheestrogenreceptor.Additionalstudiesonthenormalfunctionofthemac25genemayhelpelucidateboththenatureofthe720GenesDifferentiallyExpressedinMeningiomashormonalcomponenttomeningiomagrowthaswellastheclinicalassociationbetweenthesetumortypes.Thusfar,wehavefoundnoevidenceforgrossgenomicalterationofeitherthemac25ormac30genesinanyofourmeningiomatumorsorcelllines,indicatingthatthede-creasedexpressionofthesegenesmaybecausedbyapo-tentiallossofdifferentiationstateinthesetumorsorthatthelowexpressionstatusofthesegenesmaybeamarkerforaparticularcelltypeintheleptomeningesthatispredisposedtotumorformation.Alternatively,thedecreasedexpressionofthesegenesmayresultfromtheinactivationofan“up-stream”tumorsuppressorgene.Ourfindingthatthemac30genedemonstratesmarkedlyreducedexpressioninbothmeningiomasandothertumorsassociatedwiththedisorderNF-2raisesthepossibilitythattheupstreamgeneinfluencingmac30geneexpressionmaybethemeningiomasuscepti-bilitylocus,assumingthatthesetwodisordersarecausedbyinactivationofthesametumorsuppressorgene;thishypoth-esisobviouslyawaitsthecloningofthemslgene.Wewerequitesurprisedtofindthemac30genesimilarlydecreasedinexpressioninSchwanncelltumorsassociatedwithNF-1;thedecreasedexpressionofthisgeneinthesetumorsalone,butnotinculturesofratSchwanncells,suggeststhatme-ningiomasandSchwanncelltumorsmayshareacommonpathwayoftransformationthatinvolvesornecessitatesthedecreasedexpressionofmac30.Todate,wehavenotyetdeterminedthenatureofthesizealterationsinthemacPigeneinourmeningiomas.Althoughitispossiblethatthisgenehassufferedmutationsthataffecttranscriptsizeinthesetumors,itisalsopossiblethatthisgeneissubjecttoextensivealternativesplicinginthesecells.Inthelatterevent,itmightbeexpectedthatdifferentspliceformsofthisgenecouldbecorrelatedwithphenotypicvan-ables,suchasmeningiomasubtype,makingthisgeneusefulasaphenotypicmarkerinclinicalstudies.Additionally,ourfindingthatthemajortranscriptforthemacPigeneislikelytobelimitedinexpressiontoleptomeningealcellsfacilitatesitsuseasamarkerspecificformeningiomas.Ourunderlyinghypothesisforthisstudywasthatgenesfoundtobeconsistentlydown-regulatedorotherwisealteredinexpressioninmeningiomasrelativetotheirpre-cursorcelltypewouldbecandidatesforgenesintimatelyinvolvedwithmechanismsofgrowthcontrolanddifferen-tiation.Thishypothesisisvalidatedbyourfindingthattwoofthegenesidentifiedinthisstudyhavebeenfoundtobealteredinexpressioninothertumortypesaswell.Furthercharacterizationofthesethreegenes,aswellasidentifica-tionandcharacterizationofothersuchaberrantlyexpressedgenes,willundoubtedlyleadtoabetterunderstandingofthetransformationpathwayutilizedbythesecommontumors.MaterialsandMethodsCellLinesandCellCulture.Normalhumanleptomeningealcellswereestablished,characterized,andmaintainedasde-scnibed(35).TheLTAg2Blineofimmortalizedleptomenin-gealcellswasestablishedfromprimaryculturesbytrans-fectionwithanSV4OlargeTantigenexpressionconstruct,asdetailed(35).MeningiomacelllinesT2898,T2966,T2896,T2921,T2891,andT2888wereestablishedandcharacterizedbyoneofus(K.D.Z.);thesecellsweregrowninDulbecco’smodifiedEagle’smediumsupplementedwith15%fetalbovineserumand100units/mIofpenicillinandstreptomycin.ThecelllineC4+ZnisanimmortalizedratperipheralSchwanncelllinekindlyprovidedbyGeorgeDeVnies(MedicalCollegeofVirginia)andwasculturedasdescribed(36).ThecelllineTu-87,fromarhabdoidtumorofthebrain,waskindlyprovidedbyKuangLinYing(Chil-drensHospitalofLosAngeles)andwasculturedasdescribed(37).BreastcarcinomastudiesutilizedATCCcelllinesHs578Bst(normalhumanbreast),Hs578T,andBT-483,main-tamedinDulbecco’smodifiedEagle’smedium;ZR-75-1,ZR-75-30,andT-47D,maintainedinRPMI1060;andMDA-MB-157,MDA-MB-231,andMDA-MB-453,maintainedinLiebovitz’sL-15medium;allmediaweresupplementedwith10%fetalbovineserumandantibiotics.Othercelllinesex-aminedforexpressionofcertaingenesincludedATCCcelllinesRD-ES,HeLa,Colo32ODM,K-562,Sk-mel-2,andU-373Mg;theselineswereculturedaccordingtoATCCguidelines.RNAIsolationandNorthernandSouthernBlots.TotalcellularRNAwasisolatedfromexponentiallygrowingtissueculturecellswithguanidinehydrochloride,asdescribed(38),andpoly(A)(cid:1)RNAwaspreparedusingPoly(A)Quickcolumns,accordingtothemanufacturer’sinstructions(Stratagene).Snap-frozenmeningiomas,normalleptomen-ingealtissue,vestibularschwannomas(acousticneuromas),peripheralneurofibromas,andaspinalschwannomawereprovidedbytheCooperativeHumanTissueNetwork,partoftheNationalDiseaseResearchInterchange.AdditionalNF-2tumorswerekindlyprovidedbyVincentRiccardi(NFInsti-tute);neuroblastomatumorswerekindlyprovidedbyRogerKennett(UniversityofPennsylvania).RNAfromtumorsampleswasisolatedwithRNAzol,accordingtorecommen-dationsmadebythesupplier(Cinna-Biotecx),exceptthatfrozentumortissuewasthinlyslicedwithasterilescalpeljustpriortohomogenization.Insomecases,theseRNAsamplesweretreatedwithRNase-freeDNaseI(Pharmacia)toeliminatecontaminatinggenomicDNA,usingprotocolsderivedfromthesupplier.NorthernandSouthernblotswerepreparedaccordingtopreviouslypublishedprotocols(39,40),modifiedslightlytoincludehybridizationofnitrocel-lulosefiltersinthepresenceofhepanin(41).cDNAfragmentsusedasprobesonNorthernandSouthernblotswerelabeledusingrandomoligonucleotides(42).Probesusedinthesestudiesconsistedofeitherthefull-length1.1-kbmac25cDNA,orbases146-567ofthe2.0-kbmac30cDNA,orthefull-length300-bpmacPicDNA.RNAfilterswerewashedin0.3XSSC(0.045MNaCl-0.0045Msodiumcitrate)-0.1%SDSat55#{176}C.ChromosomalmappingstudiesutilizedDNAfromtheNationalInstituteofGeneralMedicalScienceshuman/rodentsomaticcellhybridmappingpanelno.1(Co-nellInstituteforMedicalResearch),alongwithDNAfromthechromosomehybridVII-2HAT,whichcontainsasinglehumantranslocationchromosomecontainingsequencesfrom17q21-qter(32).DNAblotswerewashedin0.1XSSC-0.1%SDSat65#{176}C.cDNALibraryConstrudionandSubtradionLibraryConstrudion.cDNAlibrariesweregeneratedintheplas-midvectorpcDNAII(Invitrogen)frompoly(A)RNAfromprimaryculturesofleptomeningealcellsandthemenin-giomacelllineT2898,accordingtostandardprotocols(38).TheselibrarieswererandomlyandoligodTprimedandweresizeselectedabove100bp.Single-strandedcDNAwasiso-latedfromtheselibrariesusingtheM13rescuetechnique(43)withthephageR408usingprotocolsfromthepcDNAIImanufacturer,withthefollowingmodifications:200p1ofeachunamplifiedcDNAlibrarywereusedtoinoculate20mlofLBbroth-50mg/mIampicillin-10mivimagnesiumsul-fateandincubatedwithshakingtoanabsorbanceofa600=0.3.Thiswasinoculatedwith1X1Oilplaque-formingunitsCellGrowth&Differentiation721ofR408helperphageandincubatedwithshakingat37#{176}Cfor30mm.Then80mlofLB-ampicillin-10msamagnesiumsulfatewereadded,andthiswasincubatedwithshakingfor6-9h.Allmanipulationsofsingle-strandedDNAwerecar-nedoutusingsiliconizedplasticware(Sigma).Double-strandedDNAwasremovedfromsingle-strandedpreparationsusingamagnesium-phenolextractionandre-stnictionendonucleasedigestionprotocol,asdescribed(44).Biotinylationofsingle-strandedDNAfromthetumorlibraryusingphotobiotinacetate(Sigma),andremovalofexcessbiotin,wasperformedasdetailed(44).Tomakethesub-tractionlibraries,2pgofLMCsingle-strandedcDNAwereaddedto60pgofbiotinylatedT2898tumorcDNA,alongwith250ngofabiotinylated350-bppieceofDNAthatispresentasaninsertonlyinnonrecombinantformsofthevectorpcDNAII(Invitrogen).TheseDNAswereethanolpre-cipitatedtogether,resuspendedin5(cid:1)ilofdH2O,andaddedto5p1of2Xhybridizationsolution[1MNaCI-100mtvi4-(2-hydroxyethyl)-1-piperazineethanesulfonicacid,pH7.6-4mMEDTA-80%deionizedformamide(44)];thissolutionwasheatedto100#{176}Cfor3mm,snapcooled,andincubatedat52#{176}Cforover24h.Subtractionofhybridizedandexcessbiotinylatedsequenceswasperformedexactlyasdescribed(45),exceptthat100pgofyeasttRNA(GIBCO/BRL)wereusedascarriertoaidprecipitationinethanol.PrecipitatedcDNA,enrichedforLMC-specificsequences,waseitherin-cubatedwithT7promoterprimerandKlenowpolymerase(Pharmacia)togeneratedouble-strandedDNAandusedtotransformcompetentDH5aF’cells(GIBCO/BRL)togenerateaplasmidsubtractionlibrary(38),orwasamplifiedbyPCRforuseingeneratingaphagesubtractionlibrary.ThephagesubtractionlibrarywasgeneratedbyPCRam-plificationofnonsubtractedsequenceswithprimersspecificfortheSp6andT7promotersofthepcDNAIIvector.PCRwascarriedoutina1OO-plreactionthatwas25ms(cid:1)Tnis-HCI,pH9.5,50mMpotassiumchloride,10mivimagnesiumchlo-ride,0.2mMeachdCTP,dATP,dTTP,anddGTP,5ng4ileachprimer,and3unitsofHotTubpolymerase(Amersham),usingthefollowingprogram:94#{176}Cfor60s,40#{176}Cfor60s,and72#{176}Cfor120sfor35cycles,followedby5mmat72#{176}C.Amplifiedsequenceswereextractedwithphenol-chloroform(1:1),digestedwithXmaIIltoremovevectorse-quences,asrecommended(NewEnglandBiolabs),andbluntendedwithKlenowpolymerase(38).EcoRladaptors(Stratagene)wereligatedtorecoveredcDNA(38);unligatedadaptorswereeliminatedafterseparationona1%agarosegel(SeakemFMC).ThiscDNAwasisolatedfromaganoseusingagelextractionsystem(Qiagen)andresubtractedwith60(cid:1)igofbiotinylatedtumorcDNAexactlyasoutlinedabove.DoublysubtractedcDNAwasamplifiedbyPCRasabovewiththeEcoRladaptor-specificoligo5’-CGCTACGAAT-TCGGCACGAG-3’usingthefollowingprogram:94#{176}Cfor60s,32#{176}Cfor60s,and72#{176}Cfor120sfor15cycles,followedby94#{176}Cfor605,60#{176}Cfor60s,72#{176}Cfor120sfor25cycles,and5mmat72#{176}C.ThisPCRproductwasdigestedwithEcoRIasrecommended(NewEnglandBiolabs)andusedtogenerateaphagesubtractionlibraryinLambdaZapII(Strata-gene)followingprotocolsfurnishedbythesupplier.SubtnadioncDNALibraryScreening.DuplicateliftsofthephagesubtractionlibraryweredifferentiallyscreenedusingradiolabeledcDNAfromLTAg2BorT2898cellsthatwasgeneratedasdescribed(46),exceptthat7(cid:1)ilofrandomhexamers(Pharmacia;90a260units/mI)and3.0(cid:1)igofoligo-dT(Phanmacia)wereusedtoprimereversetranscnip-tion,and500pCiof[32P]dCTPwereadded(Amersham;>3000Ci/mmol).Duplicatefilterswerehybridizedat5x106cpm/mlofhybridizationsolution,washedat55#{176}Cin0.3XSSC-0.1%SDS,andexposedtoKodakXAR-5filmfor12-36h.Subtractedprobes,usedtoscreentheplasmidT2898sub-tractionlibrary,weregeneratedbyhybridizingradiolabeledcDNAfromLTAg2Bcellstoa5-foldexcessofpoly(A)(cid:1)RNAfromtheT2966celllineandsubtractingasoutlinedabove.Aftersubtraction,precipitatedcDNAwastreatedat45#{176}Cfor20mmwith0.5NNaOH,reprecipitatedwithethanol,anduseddirectlyasaprobe.Filterswerehybridizedat>1x10(cid:1)cpm/ml,washedat55#{176}Cin0.3xSSC-0.1%SDS,andtreatedwithaProteinaseKsolutiontoreducebackgroundhybrid-ization(47);thesefilterswereexposedonKodakXAR-5filmfor21days.ReverseTranscniption-PolymeraseChainReadion.FivepgoftotalRNAwerereversetranscribedwithmunineMoloneyleukemiavirusreversetranscniptaseusingcondi-tionsrecommendedbythesupplier(GIBCO/BRL)ina30-(cid:1)jIreaction,using4uIof90a26(cid:1)Jmlrandomhexamers(Phar-macia)asprimers.Onep1ofthisreactionwasusedina1OO-plPCRreaction.PCRwasperformedasdescribedaboveusingthefollowingprogram:94#{176}Cfor60s,60#{176}Cfor60s,and72#{176}Cfor60sfor20cycles,followedby72#{176}Cfor10mm.Sampleswereextractedwithphenol-chloroform(1:1)andethanolprecipitatedbeforeelectrophoresison1%agarose;formac30,thesegelswereblottedovernightandhybridizedasdescribed(40).Primersformac3Owere5’-GCTGCGTGAAGTGGCTGCTGGGCCT-3’(sense)and5’-TAGGGGCTCCGCAACATGAAA-3’(antisense).Primersforactinwere5’-CTACAATGAGCTGCGTGTGGC-3’(sense)and5‘-CAGGTCCAGACGCAGGATGGC-3’(antisense).Primersforthehumanestrogenreceptor,kindlyprovidedbyC.RichardLyttle(UniversityofPennsylvania),were5’-GGAGACATGAGAGCTGCCAAC-3’(sense)and5’-CCAG-CAGCATGTCGAAGATC-3’(antisense).AllreactionsweremonitoredforcontaminationwithgenomicDNAbyinclu-sionofacontrolincubatedwithoutreversetranscniptase.cDNALibraryScreeningandSequenceAnalysisofcDNA.cDNAlibrariesscreenedforlargercDNAclonesin-cludedaskinfibroblastcDNAlibrary(Stratagene)andaHeLacDNAlibrary(courtesyofThomasKadesch,UniversityofPennsylvania).DNAsequencingwasperformedusingthedideoxychainterminationmethodofSangeretal.(48),withSequenaseenzyme(U.S.Biochemical).SequenceanalysesanddatabasesearcheswereperformedusingtheWisconsinGCGprogram(49).NucleotideSequenceAccessionNumbers.Nucleotidesequencedataforthe1.1-kbmac25cDNAandthe2.0-kbmac30cDNAweresubmittedtotheGenBankdatabaseandassignedtheaccessionnumbersLi9182andLi9183,re-spectively.AcknowledgmentsTheauthorswishtothankVincentRiccardiforsupportandfortumorsamplesandJohnLandersandDaleHainesforcriticalreadingofthemanuscript.References1.Russell,D.S.,andRubenstein,L.J.PathologyofTumorsoftheNervousSystem,pp.449-532.Baltimore:Williams&Wilkins,1989.2.Scheithauer,B.W.Tumorsofthemeninges:proposedmodificationsoftheWorldHealthOrganizationclassifications.ActaNeuropathol.,80:343-354,1990.3.Martuza,R.L.,andEldridge,R.Medicalprogress:neurofibromatosis2.N.EngI.J.Med.,318:684-688,1988.722GenesDifferentiallyExpressedinMeningiomas4.Zankl,H.,andZang,K.D.Cytologicalandcytogeneticalstudiesonbraintumors.IV.IdentificationofthemissingGchromosomeinhumanmenin-giomasasnumber22byfluorescencetechnique.Hum.Genet.,14:167-169,1972.5.Zang,K.D.Cytologicalandcytogeneticalstudiesonhumanmeningioma.CancerGenet.Cytogenet.,6:249-274,1982.6.Meese,E.,Blin,N.,andZang,K.D.Lossofheterozygosityandtheoriginofmeningioma.Hum.Genet.,77:349-351,1987.7.Seizinger,B.R.,deIaMonte,S.,Atkins,L.,Gusella,J.F.,andMartuza,R.L.Molecular-geneticapproachtohumanmeningioma:lossofgenesonchromosome22.Proc.NatI.Acad.Sci.USA,84:5419-5423,1987.8.Zankl,H.,andZang,K.D.Correlationsbetweenclinicalandcytogeneticaldatain180meningiomas.CancerGenet.Cytogenet.,1:351-356,1980.9.Dumanski,J.P.,Carlbom,E.,Collins,V.P.,andNordenskjold,M.Deletionmappingofalocusonhumanchromosome22involvedintheoncogenesisofmeningioma.Proc.NatI.Acad.Sci.USA,84:9275-9279,1987.10.Herzog,R.,Gottert,E.,Henn,W.,Zang,K.,Blin,N.,Trent,j.,andMeese,E.Large-scalephysicalmappingwithintheregion22q12.3-13.1inmenin-gioma.Genomics,10:1041-1046,1991.11.LeKanne-Deprez,R.H.,Green,N.A.,vonBiezen,N.A.,Hagemeijer,A.,vanDrune,E.,Koper,j.W.,Avezaat,C.J.J.,Bootsma,D.,andZwarthoff,E.C.At(4;22)inameningiomapointstothelocalizationofaputativetumor-suppressorgene.Am.I.Hum.Genet.,48:783-790,1991.12.Rouleau,G.A.,Wertelecki,W.,Haines,J.L.,Hobbs,W.J.,Trofatter,J.A.,Seizinger,B.R.,Martuza,R.L.,Superneau,D.W.,Conneally,P.M.,andGusella,J.F.GeneticlinkageofbilateralacousticneurofibromatosistoaDNAmarkeronchromosome22.Nature(Lond.),329:246-248,1987.13.Wertelecki,W.,Rouleau,G.,Superneau,D.W.,Forehad,L.W.,Willi-ams,J.P.,Haines,J.L.,andGusella,J.F.Neurofibromatosis2:clinicalandDNAlinkagestudiesofalargekindred.N.Engl.j.Med.,319:278-283,1988.14.Seizinger,B.R.,Martuza,R.L.,andGusella,j.F.Lossofgenesonchro-mosome22intumorigenesisofhumanacousticneuroma.Nature(Lond.),322:644-647,1986.15.Seizinger,B.R.,Rouleau,G.,Ozelius,L.J.,Lane,A.H.,St.George-Hyslop,P.,Huson,S.,Gusella,j.F.,andMartuza,R.L.Commonpathogeneticmechanismforthreetumortypesinbilateralacousticneurofibromatosis.Sci-ence(WashingtonDC),236:317-319,1987.16.Dumanski,J.P.,Rouleau,G.A.,Nordenskjold,M.,andCollins,V.P.Moleculargeneticanalysisofchromosome22in81casesofmeningioma.CancerRes.,50:5863-5867,1990.17.Maltby,E.L.,Ironside,J.W.,andBattersby,R.D.E.Cytogeneticstudiesin50meningiomas.CancerGenet.Cytogenet.,31:199-210,1988.18.Rey,j.A.,Bello,M.j.,deCampos,J.M.,Kusak,M.E.,andMoreno,S.Chromosomalinvolvementsecondaryto-22inhumanmeningiomas.Can-cerGenet.Cytogenet.,33:275-290,1988.19.Rey,I.A.,Bello,M.J.,deCampos,J.M.,andKusak,M.E.Incidenceandoriginofdicentricchromosomesinculturedmeningiomas.CancerGenet.Cytogenet.,35:55-60,1988.20.Bowes,C.,Danciger,M.,Kozak,C.A.,andFarber,D.B.IsolationofacandidatecDNAforthegenecausingretinaldegenerationintherdmouse.Proc.NatI.Acad.Sci.USA,86:9722-9726,1989.21.Travis,G.H.,Brennan,M.B.,Danielson,P.E.,Kozak,C.A.,andSutcliffe,I.G.Identificationofaphotoreceptor-specificmRNAencodedbythegeneresponsibleforretinaldegenerationslow(rds).Nature(Lond.),338:70-73,1989.22.Shtivelman,E.,andBishop,j.M.ExpressionofCD44isrepressedinneuroblastomacells.Mol.Cell.Biol.,11:5446-5453,1991.23.Lee,S.W.,Tomasetto,C.,andSager,R.Positiveselectionofcandidatetumor-suppressorgenesbysubtractivehybridization.Proc.NatI.Acad.Sci.USA,88:2825-2829,1991.24.Schweinfest,C.,Henderson,K.W.,Gu,J-R.,Kottaridis,S.,Besbaes,S.,Panotopoulous,E.,andPapas,I.S.SubtractivehybridizationcDNAlibrariesfromcoloncarcinomaandhepaticcancer.GeneAnal.Tech.,7:64-70,1990.25.Wieland,I.,Bohm,M.,andBogatz,S.IsolationofDNAsequencesde-letedinlungcancerbygenomicdifferencecloning.Proc.NatI.Acad.Sci.USA,89:9705-9709,1992.26.Schoenberg,B.S.,Christine,B.W.,andWhisnant,J.P.Nervoussystemneoplasmsandprimarymalignanciesofothersites:theuniqueassociationbetweenmeningiomasandbreastcancer.Neurology,25:705-712,1975.27.Burns,P.E.,jha,N.,andBain,G.0.Associationofbreastcancerwithmeningioma:areportoffivecases.Cancer(Phila.),58:1537-1539,1986.28.Knuckey,N.W.,Stoll,j.,andEpstein,M.H.Intracranialandspinalme-ningiomasinpatientswithbreastcarcinoma:casereports.Neurosurgery,25:112-117,1989.29.Price,j.E.Thebiologyofmetastaticbreastcancer.Cancer(Phila.),66:1313-1320,1990.30.Ooi,G.I.Insulin-likegrowthfactor-bindingproteins(IGFBPs):morethanjust1,2,3.Mol.Cell.Endocrinol.,71:C39-C43,1990.31.Riccardi,V.M.,andEichner,J.E.Neurofibromatosis:Phenotype,HistoryandPathogenesis.Baltimore:JohnsHopkinsUniversityPress,1986.32.George,D.L.,Phillips,J.A.,Francke,U.,andSeeburg,P.H.Thegenesforgrowthhormoneandchorionicsomatomammotropinareonthelongarmofchromosome17inregionq21-qter.Hum.Genet.,57:138-141,1981.33.Schrell,W.M.H.,Adams,E.F.,Fahlbusch,R.,Greb,R.,Jirikowski,G.,Prior,R.,andRamalho-Ortiago,J.Hormonaldependencyofcerebralme-ningiomas.Part1.Femalesexsteroidreceptorsandtheirsignificanceasspe-cificmarkersforadjuvantmedicaltherapy.J.Neurosurg.,73:743-749,1990.34.Adams,E.F.,Schrell,W.M.H.,Fahlbusch,R.,andThierauf,P.Hormonaldependencyofcerebralmeningiomas.Part2.Invitroeffectofsteroids,bro-mocriptine,andepidermalgrowthfactorongrowthofmeningiomas.J.Neu-rosurg.,73:750-755,1990.35.Murphy,M.,Chen,J-N.,andGeorge,D.L.Establishmentandcharac-terizationofahumanleptomeningealcellline.J.Neurosci.Res.,30:475-483,1991.36.Tennekoon,G.I.,Yoshino,J.,Peden,K.W.C.,Bogbee,j.,Rutkowski,J.L.,Kishimoto,Y.,DeVries,G.H.,andMcKhann,G.M.Transfectionofneo-natalratSchwanncellswithSV-40largeTantigengeneundercontrolofthemetallothioneinpromoter.J.CellBiol.,105:2315-2325,1987.37.Karnes,P.5.,Iran,I.N.,Ho,H.Y.,Boquiren,D.I.,Cui,M.Y.,Weissman,B.E.,Bogenmann,E.,lsaacs,H.,Shimada,H.,Barranger,J.A.,andYing,K.L.Theestablishmentofamalignantrhabdoidtumorcelllinewithaspecificchromosomaltranslocation,t(11p;22q).CancerGenet.Cytogenet.,41:B17,1989.38.Sambrook,J.,Fritsch,E.F.,andManiatis,T.MolecularCloning:ALabo-ratoryManual,2nded.NewYork:ColdSpringHarborPress,1989.39.George,D.L.,Scott,A.F.,Trusko,S.,Glick,B.,Ford,E.,andDorney,D.J.StructureandexpressionofamplifiedcKi-rasgenesequencesinYlmouseadrenaltumorcells.EMBOJ.,4:1199-1203,1985.40.George,D.L.,andPowers,V.E.CloningofDNAfromdoubleminutesofYlmouseadrenocorticaltumorcells:evidenceforgeneamplification.Cell,24:117-123,1981.41.Singh,L.,andJones,K.W.Theuseofheparinasasimple,cost-effectivemeansofcontrollingbackgroundinnucleicacidhybridizationprocedures.NucleicAcidsRes.,12:5627-5638,1984.42.Feinberg,A.P.,andVogelstein,B.AtechniqueforradiolabelingDNArestrictionendonucleasefragmentstohighspecificactivity.Anal.Biochem.,132:6-13,1983.43.Vieira,J.,andMessing,J.Preparationofsingle-strandedplasmidDNA.MethodsEnzymol.,153:3-11,1987.44.Rubenstein,J.L.R.,Brice,A.E.,Ciaranello,R.D.,Denney,D.,Porteus,M.H.,andUsdin,I.B.Subtractivehybridizationsystemusingsingle-strandedphagemidswithdirectionalinserts.NucleicAcidsRes.,18:4833-4842,1990.45.Sive,H.L.,andSt.John,I.Asimplesubtractivehybridizationtechniqueemployingphotoactivatiblebiotinandphenolextraction.NucleicAcidsRes.,16:10937,1988.46.Kriegler,M.GeneTransferandExpression:ALaboratoryManual,pp.139-146.NewYork:StocktonPress,1990.47.Yancopoulos,G.D.,OItz,E.M.,Rathburn,G.,Berman,J.E.,Smith,R.K.,Lansford,R.D.,Rothman,P.,Okada,A.,Lee,G.,Morrow,M.,Kaplan,K.,Prockop,S.,andAlt,F.W.Isolationofcoordinately-regulatedgenesthatareexpressedindiscretestagesofB-celldevelopment.Proc.NatI.Acad.Sci.USA,87:5759-5763,1990.48.Sanger,F.,Nicklen,S.,andCoulsen,A.R.DNAsequencingwithchain-terminatinginhibitors.Proc.NatI.Acad.Sci.USA,74:5463-5467,1977.49.GeneticsComputerGroup.ProgramManualfortheGCGPackage,ver-sion7.WI:GeneticsComputerGroup,1991.